Transaction DateRecipientSharesTypePriceValue
30th September 2020Jennifer Schranz301Payment by withholding$0.53$160.43
30th September 2020Robert Crotty366Payment by withholding$0.53$195.08
30th September 2020Theodore R Schroeder1,211Payment by withholding$0.53$645.46
30th September 2020Francesco Maria Lavino366Payment by withholding$0.53$195.08
30th September 2020Gary Sender312Payment by withholding$0.53$166.30
30th September 2020Steven P. Gelone628Payment by withholding$0.53$334.72
31st August 2020Gary Sender312Payment by withholding$0.62$193.25
31st August 2020Francesco Maria Lavino366Payment by withholding$0.62$226.70
31st August 2020Jennifer Schranz301Payment by withholding$0.62$186.44
31st August 2020Steven P. Gelone628Payment by withholding$0.62$388.98
Nabriva Therapeutics Plc
Nabriva Therapeutics Plc logo

Nabriva Therapeutics Plc is a clinical stage biopharmaceutical company. It engages in the research and development of novel antibiotics to treat serious infections. The company was founded in October 2005 and is headquartered in Dublin, Ireland.

Ticker: NBRV
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1641640
Employees: 162
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags